Lumito AB (publ) (NGM:LUMITO)
3.265
-0.050 (-1.51%)
At close: May 5, 2026
Lumito AB Earnings Call Transcripts
Fiscal Year 2025
-
A new tissue diagnostics platform aims to reduce subjectivity and human error using nanoparticle technology, targeting a $1.8 billion global market. Early commercialization is underway with CRO partnerships, and expansion is prioritized in Europe before North America.